Advertisement
Screener

ImmuCell Corporation (ICCC) Comprehensive Income

2.8 / 5 stars · 68/120 Roast Me

ImmuCell Corporation Comprehensive Income

ImmuCell Corporation (ICCC) reported Comprehensive Income of -$78.29 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.

Discontinued › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2022-03-30

  • ImmuCell Corporation comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-12-31 was $74.13K, a 60.74% decline year-over-year.
  • ImmuCell Corporation comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-09-30 was $147.76K.
  • ImmuCell Corporation comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-06-30 was $141.11K.
  • ImmuCell Corporation comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-03-31 was -$441.30K.
  • ImmuCell Corporation comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$78.29K.
  • ImmuCell Corporation comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$978.22K.
  • ImmuCell Corporation comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was -$1.37M.
  • ImmuCell Corporation comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$2.29M.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month
2021-12-31$74.13K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
$221.90K
derived: sum of 2 quarters · filed 2022-03-30
$363.01K
derived: sum of 3 quarters · filed 2022-03-30
-$78.29K
10-K · filed 2022-03-30
2021-09-30$147.76K
10-Q · filed 2021-11-15
$288.88K
derived: sum of 2 quarters · filed 2021-11-15
-$152.43K
10-Q · filed 2021-11-15
$36.40K
derived: sum of 4 quarters · filed 2022-03-30
2021-06-30$141.11K
10-Q · filed 2021-08-12
-$300.19K
10-Q · filed 2021-08-12
-$111.36K
derived: sum of 3 quarters · filed 2022-03-30
-$434.25K
derived: sum of 4 quarters · filed 2022-03-30
2021-03-31-$441.30K
10-Q · filed 2021-05-13
-$252.47K
derived: sum of 2 quarters · filed 2022-03-30
-$575.36K
derived: sum of 3 quarters · filed 2022-03-30
-$1.34M
derived: sum of 4 quarters · filed 2022-03-30
2020-12-31$188.83K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
-$134.06K
derived: sum of 2 quarters · filed 2022-03-30
-$899.85K
derived: sum of 3 quarters · filed 2022-03-30
-$978.22K
10-K · filed 2022-03-30
2020-09-30-$322.89K
10-Q · filed 2021-11-15
-$1.09M
derived: sum of 2 quarters · filed 2021-11-15
-$1.17M
10-Q · filed 2021-11-15
-$1.46M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30-$765.79K
10-Q · filed 2021-08-12
-$844.16K
10-Q · filed 2021-08-12
-$1.13M
derived: sum of 3 quarters · filed 2021-08-12
-$1.66M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$78.37K
10-Q · filed 2021-05-13
-$367.49K
derived: sum of 2 quarters · filed 2021-05-13
-$892.34K
derived: sum of 3 quarters · filed 2021-05-13
-$1.57M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31-$289.12K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30
-$813.97K
derived: sum of 2 quarters · filed 2021-03-30
-$1.49M
derived: sum of 3 quarters · filed 2021-03-30
-$1.37M
10-K · filed 2021-03-30
2019-09-30-$524.85K
10-Q · filed 2020-11-12
-$1.20M
derived: sum of 2 quarters · filed 2020-11-12
-$1.08M
10-Q · filed 2020-11-12
-$2.18M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30-$673.16K
10-Q · filed 2020-08-12
-$555.67K
10-Q · filed 2020-08-12
-$1.65M
derived: sum of 3 quarters · filed 2020-08-12
-$1.89M
derived: sum of 4 quarters · filed 2020-08-12
2019-03-31$117.49K
10-Q · filed 2020-05-13
-$978.38K
derived: sum of 2 quarters · filed 2020-05-13
-$1.21M
derived: sum of 3 quarters · filed 2020-05-13
-$2.00M
derived: sum of 4 quarters · filed 2020-05-13
2018-12-31-$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27
-$1.33M
derived: sum of 2 quarters · filed 2020-03-27
-$2.11M
derived: sum of 3 quarters · filed 2020-03-27
-$2.29M
10-K · filed 2020-03-27
2018-09-30-$235.63K
10-Q · filed 2019-11-12
-$1.02M
derived: sum of 2 quarters · filed 2019-11-12
-$1.20M
10-Q · filed 2019-11-12
-$1.37M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$782.12K
10-Q · filed 2019-08-12
-$959.39K
10-Q · filed 2019-08-12
-$1.13M
derived: sum of 3 quarters · filed 2019-08-12
-$1.47M
derived: sum of 4 quarters · filed 2019-08-12
2018-03-31-$177.26K
10-Q · filed 2019-05-13
-$352.07K
derived: sum of 2 quarters · filed 2019-05-13
-$689.60K
derived: sum of 3 quarters · filed 2019-05-13
-$916.46K
derived: sum of 4 quarters · filed 2019-05-13
2017-12-31-$174.81K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22
-$512.33K
derived: sum of 2 quarters · filed 2019-03-22
-$739.20K
derived: sum of 3 quarters · filed 2019-03-22
-$144.88K
10-K · filed 2019-03-22
2017-09-30-$337.52K
10-Q · filed 2018-11-13
-$564.39K
derived: sum of 2 quarters · filed 2018-11-13
$29.93K
10-Q · filed 2018-11-13
$166.33K
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$226.87K
10-Q · filed 2018-08-13
$367.45K
10-Q · filed 2018-08-13
$503.85K
derived: sum of 3 quarters · filed 2018-08-13
$554.25K
derived: sum of 4 quarters · filed 2018-08-13
2017-03-31$594.31K
10-Q · filed 2018-05-14
$730.72K
derived: sum of 2 quarters · filed 2018-05-14
$781.11K
derived: sum of 3 quarters · filed 2018-05-14
$741.74K
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31$136.41K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29
$186.80K
derived: sum of 2 quarters · filed 2018-03-29
$147.43K
derived: sum of 3 quarters · filed 2018-03-29
$534.80K
10-K · filed 2018-03-29
2016-09-30$50.39K
10-Q · filed 2017-11-13
$11.02K
derived: sum of 2 quarters · filed 2017-11-13
$398.40K
10-Q · filed 2017-11-13
$708.34K
derived: sum of 4 quarters · filed 2017-11-13
2016-06-30-$39.37K
10-Q · filed 2017-08-14
$348.00K
10-Q · filed 2017-08-14
$657.94K
derived: sum of 3 quarters · filed 2017-08-14
$960.09K
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$387.37K
10-Q · filed 2017-05-11
$697.32K
derived: sum of 2 quarters · filed 2017-05-11
$999.46K
derived: sum of 3 quarters · filed 2017-05-11
$1.10M
derived: sum of 4 quarters · filed 2017-05-11
2015-12-31$309.94K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30
$612.09K
derived: sum of 2 quarters · filed 2017-03-30
$711.14K
derived: sum of 3 quarters · filed 2017-03-30
$1.19M
10-K · filed 2017-03-30
2015-09-30$302.14K
10-Q · filed 2016-11-10
$401.20K
derived: sum of 2 quarters · filed 2016-11-10
$876.37K
10-Q · filed 2016-11-10
$1.00M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$99.05K
10-Q · filed 2016-08-11
$574.23K
10-Q · filed 2016-08-11
$701.17K
derived: sum of 3 quarters · filed 2016-08-11
$716.51K
derived: sum of 4 quarters · filed 2016-08-11
2015-03-31$475.18K
10-Q · filed 2016-05-11
$602.12K
derived: sum of 2 quarters · filed 2016-05-11
$617.46K
derived: sum of 3 quarters · filed 2016-05-11
$319.26K
derived: sum of 4 quarters · filed 2016-05-11
2014-12-31$126.94K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25
$142.29K
derived: sum of 2 quarters · filed 2016-03-25
-$155.91K
derived: sum of 3 quarters · filed 2016-03-25
-$170.65K
10-K · filed 2016-03-25
2014-09-30$15.35K
10-Q · filed 2015-11-12
-$282.85K
derived: sum of 2 quarters · filed 2015-11-12
-$297.59K
10-Q · filed 2015-11-12
-$442.29K
derived: sum of 4 quarters · filed 2016-03-25
2014-06-30-$298.20K
10-Q · filed 2015-08-13
-$312.94K
10-Q · filed 2015-08-13
-$457.64K
derived: sum of 3 quarters · filed 2016-03-25
-$400.25K
derived: sum of 4 quarters · filed 2016-03-25
2014-03-31-$14.74K
10-Q · filed 2015-05-12
-$159.44K
derived: sum of 2 quarters · filed 2016-03-25
-$102.05K
derived: sum of 3 quarters · filed 2016-03-25
2013-12-31-$144.70K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25
-$87.31K
derived: sum of 2 quarters · filed 2016-03-25
$147.68K
10-K · filed 2016-03-25
2013-09-30$57.39K
10-Q · filed 2014-11-12
$292.38K
10-Q · filed 2014-11-12
2012-12-31$80.20K
10-K · filed 2015-03-26
2012-03-31$160.37K
10-Q · filed 2012-05-14
$158.19K
derived: sum of 2 quarters · filed 2012-05-14
-$6.31K
derived: sum of 3 quarters · filed 2012-05-14
-$277.91K
derived: sum of 4 quarters · filed 2012-05-14
2011-12-31-$2.18K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27
-$166.68K
derived: sum of 2 quarters · filed 2012-03-27
-$438.28K
derived: sum of 3 quarters · filed 2012-03-27
-$459.95K
10-K · filed 2012-03-27
2011-09-30-$164.50K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
-$436.11K
derived: sum of 2 quarters · filed 2011-11-14
-$457.77K
10-Q · filed 2011-11-14
-$536.79K
derived: sum of 4 quarters · filed 2012-05-14
2011-06-30-$271.61K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-15
-$293.27K
10-Q · filed 2011-08-15
-$372.29K
derived: sum of 3 quarters · filed 2012-05-14
-$608.62K
derived: sum of 4 quarters · filed 2012-05-14
2011-03-31-$21.67K
10-Q · filed 2012-05-14
-$100.69K
derived: sum of 2 quarters · filed 2012-05-14
-$337.02K
derived: sum of 3 quarters · filed 2012-05-14
2010-12-31-$79.02K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27
-$315.35K
derived: sum of 2 quarters · filed 2012-03-27
-$375.05K
10-K · filed 2012-03-27
2010-09-30-$236.33K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
-$296.04K
10-Q · filed 2011-11-14
2010-06-30-$59.70K
10-Q · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92